Award
75A50325F80013
View source record on USAspending.gov ↗OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 47781-470-13); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 47781-468-13); 10 CT. BLISTERS PACKS.
- Recipient
- ALVOGEN, INC.
- Awarding agency
- Department of Health and Human Services
- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Fiscal year
- FY2025
- Obligated (promised)
- $227,679,090
- Total obligation (detail)
- $227,679,090
- Potential value (ceiling)
- $227,679,090
- Outlaid (paid out, linked File C)
- no linked financial data
- Signed
- Jun 29, 2025
- Period of performance
- Jun 30, 2025 – Jun 29, 2027
- Competition
- FULL AND OPEN COMPETITION
- Offers received
- 3
- Solicitation
- SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
- Pricing
- FIRM FIXED PRICE
- NAICS
- 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
- Award type
- DELIVERY ORDER
Transactions (2)
| 0 | Jun 29, 2025 | — | $227,679,090 | OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 47781-470-13); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 47781-468-13); 10 CT. BLISTERS PACKS. |
| P00001 | Jul 2, 2025 | OTHER ADMINISTRATIVE ACTION | $0 | OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 47781-470-13); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 47781-468-13); 10 CT. BLISTERS PACKS. |
Record history in our archive
Outlay keeps a content-hashed copy of this record from every pull. No post-publication revisions observed so far.
- detailfirst capture